High importanceWaiting for 10 Nov
Surgical sales
ExpectedSurgical sales of $1.49 billionanalysts' consensus
The resultComes with the report on 10 Nov
Surgical products are Alcon’s largest business, so their sales are central to its growth.
77/100B74.930
USD
-1.61
(-2.10%)
Post Trading·74.900USD-0.030(-0.04%)
Last updated: · Delayed 15 min
Fair value80.19Plus-7%46Price 74.93171
Q3 FY2026 · Earnings report
EPS estimate 0.89Revenue estimate 2.68B
Q3 FY2026 · Earnings report
EPS estimate 0.89Revenue estimate 2.68B
Alcon earnings
Alcon reports its Q3 FY2026 results on 10 November 2026. Analysts expect earnings per share of 0.89 USD and revenue of 2.68B USD.
In Q2 FY2026, reported on 10 August 2026, Alcon earned 0.84 USD a share against the 0.77 USD analysts expected (+9.1%), on revenue of 2.79B USD against 2.72B USD (+2.5%).
- Last EPS surprise
- +9.1%
- Last revenue surprise
- +2.5%
- Move after the last report
- +2.5%
- Average move after earnings
- 4.6%
EPS and revenue against estimates
Next earnings · Q3 FY2026
EPS estimate
0.89 USD
Revenue estimate
2.68B USD
Last quarter · Q2 FY2026
EPS0.84Beat +9.1%Revenue2.79BBeat +2.5%
Revenue
ReportedEstimate
EPS
ReportedEstimate
| Period | Report date | EPS estimate | Reported EPS | Surprise | EPS growth | Revenue estimate | Reported revenue | Surprise | Revenue growth | Next-day move |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 FY2026 | 0.94 | — | — | +20.58% | 2.84B | — | — | +7.90% | — | |
| Q3 FY2026 | 0.89 | — | — | +12.66% | 2.68B | — | — | +2.68% | — | |
| Q2 FY2026 | 0.77 | 0.84 | +9.09% | +10.53% | 2.72B | 2.79B | +2.54% | +7.48% | +2.5% | |
| Q1 FY2026 | 0.80 | 0.85 | +6.25% | +16.44% | 2.64B | 2.65B | +0.42% | +7.30% | -12.1% | |
| Q4 FY2025 | 0.79 | 0.78 | -1.27% | +8.33% | 2.69B | 2.64B | -1.87% | +5.35% | +2.5% | |
| Q3 FY2025 | 0.77 | 0.79 | +2.60% | -2.47% | 2.71B | 2.61B | -3.58% | +6.52% | — | |
| Q2 FY2025 | 0.71 | 0.76 | +7.04% | +2.70% | 2.65B | 2.60B | -2.06% | +3.38% | — | |
| Q1 FY2025 | 0.76 | 0.73 | -3.95% | -6.41% | 2.63B | 2.47B | -5.84% | +0.57% | — | |
| Q4 FY2024 | 0.70 | 0.72 | +2.86% | +4.35% | 2.47B | 2.50B | +1.37% | +0.95% | — | |
| Q3 FY2024 | 0.72 | 0.81 | +12.50% | +22.73% | 2.46B | 2.45B | -0.35% | +5.37% | +0.8% | |
| Q2 FY2024 | 0.74 | 0.74 | 0.00% | +7.25% | 2.52B | 2.51B | -0.35% | +3.68% | -2.0% | |
| Q1 FY2024 | 0.72 | 0.78 | +8.33% | +11.43% | 2.52B | 2.46B | -2.52% | +4.55% | +10.3% | |
| Q4 FY2023 | 0.68 | 0.69 | +1.47% | +64.29% | 2.42B | 2.48B | +2.41% | +14.16% | +5.5% | |
| Q3 FY2023 | 0.67 | 0.66 | -1.49% | +32.00% | 2.29B | 2.33B | +1.81% | +8.83% | -5.9% | |
| Q2 FY2023 | 0.62 | 0.69 | +11.29% | +9.52% | 2.33B | 2.42B | +4.16% | +9.25% | +0.1% | |
| Q1 FY2023 | 0.60 | 0.70 | +16.67% | +2.94% | 2.22B | 2.35B | +5.83% | +7.45% | +8.5% | |
| Q4 FY2022 | 0.42 | 0.42 | 0.00% | -25.00% | 2.19B | 2.17B | -0.76% | +1.02% | -3.5% | |
| Q3 FY2022 | 0.48 | 0.50 | +4.17% | -7.41% | 2.09B | 2.14B | +2.48% | +1.81% | +4.9% | |
| Q2 FY2022 | 0.55 | 0.63 | +14.55% | +12.50% | 2.25B | 2.22B | -1.52% | +5.07% | -4.7% | |
| Q1 FY2022 | 0.52 | 0.68 | +30.77% | +38.78% | 2.12B | 2.19B | +3.40% | +13.42% | +7.0% | |
| Q4 FY2021 | 0.49 | 0.56 | +14.29% | +36.59% | 2.11B | 2.15B | +1.87% | +10.77% | +2.1% | |
| Q3 FY2021 | 0.49 | 0.54 | +10.20% | +38.46% | 2.04B | 2.10B | +3.03% | +14.36% | -5.2% | |
| Q2 FY2021 | 0.43 | 0.56 | +30.23% | — | 2.04B | 2.11B | +3.42% | +73.81% | +12.1% | |
| Q1 FY2021 | 0.44 | 0.49 | +11.36% | +8.89% | 1.76B | 1.93B | +9.76% | +4.83% | -5.9% | |
| Q4 FY2020 | 0.42 | 0.41 | -2.38% | -8.89% | 1.94B | 1.94B | 0.00% | +1.41% | -2.7% | |
| Q3 FY2020 | 0.18 | 0.39 | +116.67% | -15.22% | 1.55B | 1.84B | +18.52% | -1.61% | +0.2% | |
| Q2 FY2020 | -0.17 | -0.21 | -23.53% | -144.68% | 809.33M | 1.21B | +50.00% | -36.21% | -2.2% | |
| Q1 FY2020 | 0.39 | 0.45 | +15.38% | -11.76% | 1.39B | 1.84B | +32.35% | +0.93% | +6.2% | |
| Q4 FY2019 | 0.46 | 0.45 | -2.17% | — | 1.96B | 1.91B | -2.17% | -0.05% | +7.4% | |
| Q3 FY2019 | 0.46 | 0.46 | 0.00% | — | 1.87B | 1.87B | 0.00% | +6.02% | -3.6% | |
| Q2 FY2019 | 0.48 | 0.47 | -2.08% | +1,429.45% | 1.94B | 1.90B | -2.04% | +4.56% | -3.1% | |
| Q1 FY2019 | 0.48 | 0.51 | +6.25% | — | 1.71B | 1.82B | +6.67% | — | +0.5% | |
| Q4 FY2018 | — | -0.33 | — | -351.74% | — | 1.91B | — | -71.82% | -1.7% | |
| Q3 FY2018 | — | -0.42 | — | — | — | 1.76B | — | — | — | |
| Q2 FY2018 | — | 0.03 | — | — | — | 1.82B | — | — | — | |
| Q4 FY2017 | — | 0.05 | — | — | — | 1.80B | — | — | — | |
| Q4 FY2017 | — | 0.13 | — | — | — | 6.79B | — | — | — |
| Period | EPS estimate | Reported EPS | Surprise | EPS growth | Revenue estimate | Reported revenue | Surprise | Revenue growth |
|---|---|---|---|---|---|---|---|---|
| FY2028 | 4.46 | — | — | +12.87% | 12.42B | — | — | +6.01% |
| FY2027 | 3.96 | — | — | +12.91% | 11.72B | — | — | +5.81% |
| FY2026 | 3.50 | — | — | +14.50% | 11.07B | — | — | +7.31% |
| FY2025 | 3.06 | 3.06 | -0.07% | +0.33% | 10.26B | 10.32B | +0.54% | +3.96% |
| FY2024 | 2.99 | 3.05 | +1.93% | +11.31% | 9.76B | 9.93B | +1.67% | +3.60% |
| FY2023 | 2.81 | 2.74 | -2.45% | +22.87% | 9.71B | 9.58B | -1.29% | +9.92% |
| FY2022 | 2.27 | 2.23 | -1.61% | +3.72% | 8.75B | 8.72B | -0.42% | +5.14% |
The move is the shares' change on the trading day after the report: after a report after the close, the next day's close on the report day's; before the open, the report day's close on the day before's. Surprise is the reported figure against the analysts' average estimate.
Q3 FY2026
What the market is waiting for
From the last earnings call, the company's guidance and analysts' previews, and checked against the report when it comes.
Beat record
On average, analysts' EPS estimate was 4.7% off the result, either way, and their revenue estimate 2.1%, over the last 12 quarters.
- EPS beats
- 20 / 30
- Revenue beats
- 17 / 30
- Average EPS surprise, last 12
- +3.6%
- Since
- May 2019
See also:Forecast,EPS,Income statement
Common questions about Alcon's earnings
Source: Financial Modeling Prep